MSFP
RCPI

Mark Sheptoff Financial Planning’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

Mark Sheptoff Financial Planning’s Portfolio RCPI Stock Details RCPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-20
Closed – – 450
2015
Q3 		$0 Hold
20
– – ﹤0.01% 476
2015
Q2 		$0 Buy
+20
New +$48 ﹤0.01% 417
2015
Q1 		– Sell
-20
Closed – – 358
2014
Q4 		$0 Hold
20
– – ﹤0.01% 355
2014
Q3 		$0 Hold
20
– – ﹤0.01% 367
2014
Q2 		$0 Buy
+20
New +$347 ﹤0.01% 381

Other funds holding RCPI

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return
WP
WealthPLAN Partners Omaha, Nebraska $523M AUM 23.92% 1-Year Est. Return
IWMPD
Integrated Wealth Management (Palm Desert) Palm Desert, California $299M AUM 12.85% 1-Year Est. Return

Mark Sheptoff Financial Planning's RCPI Position: Q4 2015 in Review

Mark Sheptoff Financial Planning sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q4 2015, closing a stake of 20 shares.

Mark Sheptoff Financial Planning first reported a position in RCPI in Q2 2014 and held it in 5 quarters. The position peaked at $0 in Q3 2015. 9 funds tracked by Wall St. Rank hold RCPI as of Q4 2015.

  • Mark Sheptoff Financial Planning reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q4 2015 after selling out during the quarter.
  • Mark Sheptoff Financial Planning sold 20 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q4 2015.
  • Mark Sheptoff Financial Planning first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 5 quarters.
  • Mark Sheptoff Financial Planning's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $0 in Q3 2015.
  • 9 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q4 2015.

Based on Mark Sheptoff Financial Planning's 13F filing for Q4 2015, filed 9 Feb 2016.